Cargando…

High EVI1 Expression Predicts Adverse Outcomes in Children With De Novo Acute Myeloid Leukemia

BACKGROUND: A high ecotropic viral integration site 1 (EVI1) expression (EVI1 (high)) is an independent prognostic factor in adult acute myeloid leukemia (AML). However, little is known of the prognostic value of EVI1 (high) in pediatric AML. This study aimed to examine the biological and prognostic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zheng, Yongzhi, Huang, Yan, Le, Shaohua, Zheng, Hao, Hua, Xueling, Chen, Zaisheng, Feng, Xiaoqin, Li, Chunfu, Zheng, Mincui, Xu, Honggui, He, Yingyi, He, Xiangling, Li, Jian, Hu, Jianda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474639/ https://www.ncbi.nlm.nih.gov/pubmed/34589425 http://dx.doi.org/10.3389/fonc.2021.712747

Ejemplares similares

Clinical characteristics and prognosis analysis of patients with de novo ASXL1 ‐mutated AML treated with the C‐HUNAN‐AML‐15 protocol: A multicenter study by the South China Pediatric AML Collaborative Group
por: Zeng, Minhui, et al.
Publicado: (2023)

Evaluating the prognostic value of CD56 in pediatric acute myeloid leukemia
por: Liang, Tianqi, et al.
Publicado: (2022)

Global Identification of EVI1 Target Genes in Acute Myeloid Leukemia
por: Glass, Carolyn, et al.
Publicado: (2013)

Adverse reactions after treatment with dasatinib in chronic myeloid leukemia: Characteristics, potential mechanisms, and clinical management strategies
por: Cheng, Fang, et al.
Publicado: (2023)

Aberrant EVI1 splicing contributes to EVI1-rearranged leukemia
por: Tanaka, Atsushi, et al.
Publicado: (2022)

EVI1 in Leukemia and Solid Tumors
por: Liang, Beiyuan, et al.
Publicado: (2020)

Evi1 defines leukemia-initiating capacity and tyrosine kinase inhibitor resistance in chronic myeloid leukemia
por: Sato, T, et al.
Publicado: (2014)

High EVI1 Expression due to NRIP1/EVI1 Fusion in Therapy-related Acute Myeloid Leukemia: Description of the First Pediatric Case
por: D’Angiò, Mariella, et al.
Publicado: (2020)

TS Gene Polymorphisms Correlate with Susceptibility to Acute Lymphocytic Leukemia in Children
por: Zou, Runyin, et al.
Publicado: (2017)

Prognostic Value of EVI1 Expression in Pediatric Acute Myeloid Leukemia: A Systematic Review
por: Sadeghian, Mohammad Hadi, et al.
Publicado: (2018)

S116: CELLULAR AND MOLECULAR MECHANISMS OF EVI1-EXPRESSING MLL-REARRANGED ACUTE MYELOID LEUKEMIA
por: Châtel-Soulet, Hugues-Etienne, et al.
Publicado: (2022)

Long-term outcomes of frontline imatinib therapy for chronic myeloid leukemia in China
por: Cheng, Fang, et al.
Publicado: (2023)

FLT3-TKD in the prognosis of patients with acute myeloid leukemia: A meta-analysis
por: Li, Shuping, et al.
Publicado: (2023)

Efficacy of All-Trans-Retinoic Acid in High-Risk Acute Myeloid Leukemia with Overexpression of EVI1
por: Paubelle, Etienne, et al.
Publicado: (2019)

Resistance to Hypomethylating Agents in Myelodysplastic Syndrome and Acute Myeloid Leukemia From Clinical Data and Molecular Mechanism
por: Zhao, Guangjie, et al.
Publicado: (2021)

EVI1 dysregulation: impact on biology and therapy of myeloid malignancies
por: Birdwell, Christine, et al.
Publicado: (2021)

P338: SLC7A11 PROMOTES ARGININE BIOSYNTHESIS IN ACUTE LYMPHOBLASTIC LEUKEMIA WITH IMMUNOTHERAPEUTIC POTENTIAL
por: LI, Jiazheng, et al.
Publicado: (2023)

Screening the Cancer Genome Atlas Database for Genes of Prognostic Value in Acute Myeloid Leukemia
por: Ni, Jie, et al.
Publicado: (2020)

FBXW4 Is Highly Expressed and Associated With Poor Survival in Acute Myeloid Leukemia
por: Han, Qi, et al.
Publicado: (2020)

Antigen-Specific TCR-T Cells for Acute Myeloid Leukemia: State of the Art and Challenges
por: Kang, Synat, et al.
Publicado: (2022)

The successful combination of grapefruit juice and venetoclax in an unfit acute myeloid leukemia patient with adverse risk: A case report
por: Long, Zhangbiao, et al.
Publicado: (2022)

Higher TOX Genes Expression Is Associated With Poor Overall Survival for Patients With Acute Myeloid Leukemia
por: Liang, Chaofeng, et al.
Publicado: (2021)

Targeting Bcl-2 Proteins in Acute Myeloid Leukemia
por: Wei, Yunxiong, et al.
Publicado: (2020)

Methylation of SPRED1: A New Target in Acute Myeloid Leukemia
por: Su, Nan, et al.
Publicado: (2022)

Evi1 upregulates Fbp1 and supports progression of acute myeloid leukemia through pentose phosphate pathway activation
por: Mizuno, Hideaki, et al.
Publicado: (2021)

High HSPA8 expression predicts adverse outcomes of acute myeloid leukemia
por: Li, Jun, et al.
Publicado: (2021)

Pharmacokinetics of single- and multiple-dose flumatinib in patients with chronic phase chronic myeloid leukemia
por: Jiang, Bo, et al.
Publicado: (2023)

Anti-Tumor Effects of BDH1 in Acute Myeloid Leukemia
por: Han, Fei, et al.
Publicado: (2021)

A distinct lipid metabolism signature of acute myeloid leukemia with prognostic value
por: Li, Ding, et al.
Publicado: (2022)

Myeloid Derived Suppressor Cells in Chronic Myeloid Leukemia
por: Giallongo, Cesarina, et al.
Publicado: (2015)

SPRED1 Is Downregulated and a Prognostic Biomarker in Adult Acute Myeloid Leukemia
por: Zhang, Rui, et al.
Publicado: (2020)

The Molecular Mechanisms of Resistance to IDH Inhibitors in Acute Myeloid Leukemia
por: Zhuang, Xiaomei, et al.
Publicado: (2022)

Comprehensive analysis of ferroptosis-related gene signatures as a potential therapeutic target for acute myeloid leukemia: A bioinformatics analysis and experimental verification
por: Zheng, Zhiyuan, et al.
Publicado: (2022)

Aberrant Chloride Intracellular Channel 4 Expression Is Associated With Adverse Outcome in Cytogenetically Normal Acute Myeloid Leukemia
por: Huang, Sai, et al.
Publicado: (2020)

Corrigendum: Targeting Bcl-2 Proteins in Acute Myeloid Leukemia
por: Wei, Yunxiong, et al.
Publicado: (2020)

Dose optimization strategy of the tyrosine kinase inhibitors imatinib, dasatinib, and nilotinib for chronic myeloid leukemia: From clinical trials to real-life settings
por: Cheng, Fang, et al.
Publicado: (2023)

Hsa_circ_0012152 and Hsa_circ_0001857 Accurately Discriminate Acute Lymphoblastic Leukemia From Acute Myeloid Leukemia
por: Guo, Shanshan, et al.
Publicado: (2020)

Research progress on molecular biomarkers of acute myeloid leukemia
por: Yin, Pei-Yuan, et al.
Publicado: (2023)

The PI3K/AKT Pathway Inhibitor ISC-4 Induces Apoptosis and Inhibits Growth of Leukemia in Preclinical Models of Acute Myeloid Leukemia
por: Annageldiyev, Charyguly, et al.
Publicado: (2020)

Therapeutic targeting of leukemia stem cells in acute myeloid leukemia
por: Barbosa, Karina, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0e5vnav5hemmfjijkdcnkkaon8